Exosomes are nanosized vesicles that are released from cells. They are capable of transferring MicroRNAs (miRNAs), proteins, and Messenger RNA (mRNA) between the cells. Exosomes therefore represents a potential means of intercellular communication. The global exosome diagnostics and therapeutics market will grow at a significant rate over the forecast period. Exosomes are one of the emerging markets for diagnosing cancer. The research report features of a complete quantitative and qualitative assessment of the global market. It analyzes the important prospects and evaluates market participants across the industry.
Global Exosome diagnostics and therapeutics market: Key Players
Some of the top players operating in the global market are Immune Therapy Holdings AB, Aethlon Medical, Inc., ReNeuron Group plc, Exosome Diagnostics Inc., Therapeutic Solutions International, Inc., NanoSomix Inc., Biotechnology Limited, Thermo Fisher Scientific Inc., Capricor Therapeutics, Exiqon A/S, Malvern Instruments Ltd., Sistemic Inc., System Biosciences Inc., and NX Pharmagen.
Companies are expected to focus on mergers and acquisitions to gain a competitive edge in the market. For instance, in June 2018, Bio-Techne Corporation announced its plans to acquire Exosome Diagnostics. The transaction is expected to reach completion by July or August 2019. This acquisition will give Bio-Techne Corporation full access to the revolutionary technologies developed by Exosome Diagnostics, giving the acquirer a chance to make its mark in the AR-T cell marketplace. Many companies are expected to give emphasis to diagnostic signatures to gain attention.
Get PDF template of this report: https://www.qyrconsulting.com/request-sample/7254
Global Exosome Diagnostics and Therapeutics Market: Drivers and Restraints
The growing occurrence of chronic diseases such as cancer and its need for diagnosing and screening is one of the key factors that influencing the growth of the market in the forthcoming years. The increasing potential of exosomes as carriers of functional proteins and RNA are expected to fuel the demand for exosome diagnostics and therapeutics. This is because as exosomes diagnostics and therapeutics are mainly use in the drug delivery field. Rising support from governments and regulatory bodies with respect to research grants and funding has created a positive impact on the growth of the market.
In addition, technological advancements also help to advance exosome-based products and exosome isolation for new applications. Formulation of policies and subsidy provisions from several governments have stimulated the research and development activities in exosome diagnostics and therapeutics. This led to increasing in the demand for the same.
However, the high cost of investment in the research and development activities and the lack of standardization and validation in isolation of exosomes are likely to hamper the growth of the market in the coming years.
Global Exosome Diagnostics and Therapeutics Market: Forecast by segments
The global market is segmented on the basis of product, application, and end-use.
The instrument segment is expected to grab a remarkable market share due to its frequent use in the healthcare facilities for the isolation of exosomes.
- Diagnostic Center
- Cancer Institute
North America is likely to capture significant market share in the near future due to the growing number of cancer patients in the region. Asia Pacific is also expected to be the fastest-growing region for exosomes diagnostic and therapeutic market. This is due to the increasing awareness for advanced and innovative applications for exosomes and diagnostic therapeutics.
Get Complete Report within 24 hrs: https://www.qyrconsulting.com/checkout/7254
We established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.